Relationship between p53 dysfunction, CD38 expression, and IgVH mutation in chronic lymphocytic leukemia

Blood

Volumn 100, Issue 4, 2002, Pages 1404-1409

  Lin, Ke ^a   Sherrington, Paul D ^a   Dennis, Michael ^a   Matrai, Zoltan ^a   Cawley, John C ^a   Pettitt, Andrew R ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD38 ANTIGEN; IMMUNOGLOBULIN; PROTEIN P21; PROTEIN P53;

AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CORRELATION ANALYSIS; FEMALE; HUMAN; LEUKEMOGENESIS; MAJOR CLINICAL STUDY; MALE; MUTATION; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SCREENING;

EID: 0037103272     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2001-11-0066     Document Type: Article

References (37)

1. Chronic lymphocytic leukemia
2. B-cell chronic lymphocytic leukemia: A bird of a different feather
3. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors
4. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia
5. Unmutated IgV(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia
6. Human CD38: A glycoprotein in search of a function
7. Mutational status of Ig VH genes provides clinically valuable information in B-cell chronic lymphocytic leukemia
8. CD38 expression identifies two distinct subsets in Bchronic lymphocytic leukemia (B-CLL)
9. CD38 expression is a poor predictor for VH gene mutational status and prognosis in chronic lymphocytic leukemia
10. H gene mutation in B-cell chronic lymphocytic leukemia
11. CD38 expression as an important prognostic factor in Bcell chronic lymphocytic leukemia
12. p53: Puzzle and paradigm
13. p53 the cellular gatekeeper for growth and division
14. p53 guardian of the genome
15. p53 dependent apoptosis modulates the cytotoxicity of anticancer agents
16. Purine analogues kill resting lymphocytes by p53-dependent and -independent mechanisms
17. The effect of p53 dysfunction on purine analogue cytotoxicity in chronic lymphocytic leukaemia
18. Role of poly(ADP-ribosyl)ation in the killing of chronic lymphocytic leukemia cells by purine analogues
19. p53 Gene mutation in B-cell chronic lymphocytic leukemia is associated with drug resistance and is independent of MDR1/MDR3 gene expression
20. p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies
21. p53 gene deletion predicts for poor survival and nonresponse to therapy with purine analogs in chronic B-cell leukemias
22. p53 dysfunction in B-cell chronic lymphocytic leukemia: Inactivation of ATM as an alternative to TP53 mutation
23. Inactivetion of ataxia telangiectasia mutated gene in chronic lymphocytic leukaemia
24. Deficiency of ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemia
25. Use of family specific leader region primers for PCR amplification of the human heavy chain variable region gene repertoire
26. 'Touchdown' PCR to circumvent spurious priming during gene amplification
27. bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia
28. Genomic aberrations and survival in chronic lymphocytic leukemia
29. Formation and hydrolysis of cyclic ADP-ribose catalyzed by lymphocyte antigen CD38
30. Human CD38 catalyses the production of cyclic ADPribose
31. CD38 signaling by agonistic monoclonal antibody prevents apoptosis of human germinal center B cells
32. B-lymphocyte surface molecule mediating activation and protection from apoptosis via calcium channels
33. Upregulation of CD38 expression in leukemic B cells by interferon types I and II
34. Structure and physical map of 64 variable segments in the 3′0.8-megabase region of the human immunoglobulin heavy-chain locus
35. Sites of B lymphocyte selection, activation and tolerance in spleen
36. + chronic lymphocytic leukemia B cells: A multiple time point analysis